A. F. Stewart
Journal of Clinical Endocrinology and Metabolism · 2005–2011
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom A. F. Stewart trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. F. Stewart's perspective
Ordered by how strongly the researchers A. F. Stewart trusts endorse each paper. Same corpus, a different order for every researcher.
- American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (Journal of Clinical Oncology)
- Mechanisms of bone metastasis. (Discover medicine)
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. (Journal of Clinical Oncology)
- Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. (Cancer Journal)
- Clinical use of bone densitometry: scientific review. (Journal of the American Medical Association (JAMA))
- Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. (Endocrine reviews)
- Pathogenesis of bone fragility in women and men. (The Lancet)
- Diagnosis of osteoporosis and assessment of fracture risk. (The Lancet)
- Intravenous zoledronic acid in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
- Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. (Journal of the National Cancer Institute)